Police & Firemen s Retirement System of New Jersey Sells 438 Shares of Align Technology, Inc. $ALGN

Police & Firemen s Retirement System of New Jersey decreased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 4.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,415 shares of the medical equipment provider’s stock after selling 438 shares during the period. Police & Firemen s Retirement System of New Jersey’s holdings in Align Technology were worth $1,972,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. QRG Capital Management Inc. bought a new stake in Align Technology during the 2nd quarter worth approximately $306,000. Czech National Bank grew its holdings in Align Technology by 3.3% during the second quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after buying an additional 537 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in Align Technology by 4.5% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 2,372 shares of the medical equipment provider’s stock worth $449,000 after buying an additional 102 shares in the last quarter. Navera Investment Management Ltd. raised its position in Align Technology by 3.0% in the 2nd quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider’s stock valued at $149,126,000 after buying an additional 23,080 shares during the last quarter. Finally, Acadian Asset Management LLC bought a new position in Align Technology during the 1st quarter valued at $20,194,000. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Stock Performance

Shares of ALGN stock opened at $133.68 on Thursday. The firm has a market cap of $9.59 billion, a price-to-earnings ratio of 25.91, a P/E/G ratio of 1.49 and a beta of 1.84. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $246.19. The firm’s 50-day simple moving average is $132.77 and its two-hundred day simple moving average is $158.22.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to analyst estimates of $980.75 million. Align Technology had a net margin of 9.50% and a return on equity of 14.06%. Align Technology’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the business posted $2.35 EPS. Align Technology has set its Q4 2025 guidance at EPS. Analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology declared that its Board of Directors has approved a share repurchase plan on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ALGN shares. Wells Fargo & Company reduced their target price on shares of Align Technology from $199.00 to $181.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. UBS Group reduced their price objective on shares of Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a research report on Thursday, October 16th. Mizuho dropped their target price on shares of Align Technology from $210.00 to $170.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Jefferies Financial Group boosted their target price on Align Technology from $140.00 to $155.00 in a research note on Thursday, October 30th. Finally, Morgan Stanley upped their target price on Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $175.45.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.